𝘛𝘩𝘪𝘴 𝘷𝘪𝘥𝘦𝘰 𝘪𝘴 𝘪𝘯𝘵𝘦𝘯𝘥𝘦𝘥 𝘧𝘰𝘳 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘱𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭𝘴 𝘰𝘯𝘭𝘺.
ORTHOPLASTY™ is a disposable device for treating subchondral bone lesions.
The device is to be used for the delivery of bone cement in the subchondral bone, i.e., to repair subchondral bone defects (Bone Marrow Lesions BML) or in avascular necrosis of the femur head or in other bone sites, such as the ankle, shoulder, knee. The procedure is carried out with a minimally invasive approach under fluoroscopy guidance along with arthroscopy, to target and manage of findings inside the joint.
The pathology is classified as a SIFK (Subchondral Insufficiency Fracture of the Knee) and in the initial stages of SONK (Spontaneous Osteonecrosis of the Knee).
The patient that presents with this pathology, suffers from relatively early osteoarthritis and consults the clinical specialist as a result of intense pain that does not correspond to a significantly compromised radiographic scenario.
In fact, these lesions are not visible under X-ray and only a diagnostic confirmation using MRI reveals a hyper intense uptake signal in sequences sensitive to T2 fluids (hydrogen) and in STIR sequences.
The objective of the method is to reinforce subchondral bone lesions using the same principal as
vertebroplasty and involves the percutaneous insertion, into the bone rarefaction site, of an appropriate bone substitute or of an autologous bone graft enhanced with a concentrate of mesenchymal stromal cells.
FEATURES:
minimally-invasive percutaneous approach
20 minutes procedure
rapid functional recovery
pain relief after 1 day
preservation of anatomical physiology for future operations
APPLICATIONS:
Bone Marrow Lesions in the following areas:
proximal humerus
distal femur
femoral head
proximal tibia
ankle joint
hip
For further information: www.biopsybell.it